Get the latest Science News and Discoveries

Experimental One-Dose Treatment Cuts 'Bad' Cholesterol by 52% in First Human Trial


Too much 'bad' cholesterol in the bloodstream – that's the low-density lipoprotein (LDL) type – can contribute to plaque buildup in the arteries, increasing the risk of cardiovascular problems like heart attacks and strokes.

None

Get the Android app

Or read this on Science Alert

Read more on:

Photo of Cholesterol

Cholesterol

Photo of human trial

human trial

Photo of dose treatment cuts

dose treatment cuts

Related news:

News photo

LDL-cholesterol lowering medication linked to lower mortality in high-risk patients without a prior heart attack or stroke

News photo

Cholesterol-lowering medication reduces major cardiovascular events by 30% in older people without known cardiovascular disease

News photo

An Experimental Single-Time Treatment Slashed Cholesterol for a Year